Overall rank by patents
#49,953
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G10L (Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding).
The verdict
According to USPTO PatentsView, RED ranks #49,953 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R49953 · Foreign Corporation #49,953 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Realyagu Zone Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
RED BOX Recorders · this assignee
36 score
3D Lighting… · lowest
7 score
What this shows RED's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
RED BOX Recorders Limited is a focused PatentsView assignee: 4 CPC subclasses with 80% of grants classified under G10L (Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2019. By volume, RED sits between Realyagu Zone Co., Ltd. and Regenerx Biopharmaceuticals, Inc..
RED BOX Recorders Limited shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Realyagu Zone Co., Ltd.
5 patents
Reckitt Benckiser Healthcare (UK) Limited
5 patents
Recovered Energy, Inc.
5 patents
Recyclebank LLC
5 patents
Reed Manufacturing Company
5 patents
Reform Biologics, LLC
5 patents
Regenerative Medical Solutions, Inc.
5 patents
Regenerx Biopharmaceuticals, Inc.
5 patents
RED BOX Recorders Limited
5 patents
What this shows RED holds 5 patents at rank #49,958, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #49,958 in granted patent volume.
Other assignees with the most granted patents in RED's primary technology class.
RED's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 49% higher than 51% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
| 2022 | 2 | 40.0% |
| 2023 | 1 | 20.0% |
Top 4 of 4 technology areas
Overall rank by patents
#49,953
of 49,997 tracked assignees
35.5 out of 100
What to do with this data
RED BOX Recorders Limited's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.